Sentinel Lymph Node Biopsy
"Sentinel Lymph Node Biopsy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A diagnostic procedure used to determine whether LYMPHATIC METASTASIS has occurred. The SENTINEL LYMPH NODE is the first lymph node to receive drainage from a neoplasm.
| Descriptor ID |
D021701
|
| MeSH Number(s) |
E01.370.225.500.384.100.580 E01.370.225.998.054.580 E01.370.388.100.580 E04.074.580 E04.446.819 E05.200.500.384.100.580 E05.200.998.054.580 E05.242.384.100.580
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sentinel Lymph Node Biopsy".
Below are MeSH descriptors whose meaning is more specific than "Sentinel Lymph Node Biopsy".
This graph shows the total number of publications written about "Sentinel Lymph Node Biopsy" by people in this website by year, and whether "Sentinel Lymph Node Biopsy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 1 | 2 |
| 2002 | 1 | 0 | 1 |
| 2003 | 2 | 1 | 3 |
| 2004 | 1 | 1 | 2 |
| 2005 | 3 | 0 | 3 |
| 2006 | 4 | 1 | 5 |
| 2007 | 1 | 1 | 2 |
| 2008 | 1 | 1 | 2 |
| 2009 | 1 | 2 | 3 |
| 2010 | 0 | 2 | 2 |
| 2011 | 2 | 1 | 3 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 3 | 4 |
| 2014 | 2 | 2 | 4 |
| 2015 | 6 | 0 | 6 |
| 2016 | 0 | 2 | 2 |
| 2017 | 2 | 1 | 3 |
| 2018 | 1 | 2 | 3 |
| 2019 | 0 | 1 | 1 |
| 2020 | 2 | 2 | 4 |
| 2021 | 2 | 1 | 3 |
| 2022 | 0 | 1 | 1 |
| 2023 | 1 | 0 | 1 |
| 2024 | 1 | 2 | 3 |
| 2025 | 0 | 1 | 1 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sentinel Lymph Node Biopsy" by people in Profiles.
-
Fluorescent-guided surgery and the use of indocyanine green sentinel lymph node mapping in the pediatric and young adult oncology population. Cancer. 2023 Dec 15; 129(24):3962-3970.
-
Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit. JAMA Dermatol. 2020 09 01; 156(9):1004-1011.
-
Randomized trial of endobronchial ultrasound-guided transbronchial needle aspiration under general anesthesia versus moderate sedation. Am J Respir Crit Care Med. 2015 Apr 01; 191(7):796-803.
-
Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk in women with breast cancer. JAMA Surg. 2014 Aug; 149(8):788-96.
-
Implementation of the american college of surgeons oncology group z1071 trial data in clinical practice: is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy? Ann Surg Oncol. 2014 Aug; 21(8):2468-73.
-
A case for caution in the pursuit of the sentinel node in women with endometrial carcinoma. Gynecol Oncol. 2014 Feb; 132(2):275-9.
-
Prospective assessment of lymphedema incidence and lymphedema-associated symptoms following lymph node surgery for melanoma. Melanoma Res. 2013 Aug; 23(4):290-7.
-
Complications in the surgical treatment of pediatric melanoma. J Pediatr Surg. 2013 Jun; 48(6):1249-53.
-
Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression. Cancer Epidemiol Biomarkers Prev. 2013 May; 22(5):827-34.
-
Landmark trials affecting the surgical management of invasive breast cancer. Surg Clin North Am. 2013 Apr; 93(2):501-18.